|
Jan 4
|
These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024
|
|
Jan 2
|
Is Eli Lilly Stock A Buy After FDA Pushes Back On Compounded Knockoffs?
|
|
Jan 2
|
Piper Sandler downgrades Biogen, slashes PT by $177 amid transition challenges
|
|
Jan 1
|
Why Biogen Inc. (BIIB) is a Top Value Stock for the Long-Term
|
|
Jan 1
|
The 5 worst performing stocks on the Nasdaq 100 in 2024
|